Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

319
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
319
Relative Risk01:12

Relative Risk

1.5K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.5K
Hazard Rate01:11

Hazard Rate

332
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
332
Actuarial Approach01:20

Actuarial Approach

235
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
235
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

276
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
276
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

17.4K
z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
17.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Right Stellate Ganglion Blockade as a Bridging Therapy Prior to Sympathectomy in a Hemodynamically Unstable Adolescent With Ventricular Storm Secondary to Congenital Long QT Syndrome.

Case reports in anesthesiology·2026
Same author

Impact of the left common ostium following pulmonary vein isolation in AF: Systematic review and meta-analysis.

Journal of arrhythmia·2022
Same author

Comparative Analysis between Transferred and Self-Referred STEMI Patients Undergoing Primary Angioplasty.

Arquivos brasileiros de cardiologia·2019
Same author

Unscheduled Emergency Visits after Cardiac Devices Implantation: Comparison between Cardioverter Defibrillators and Cardiac Resynchronization Therapy Devices in less than one year of Follow Up.

Arquivos brasileiros de cardiologia·2019
Same author

Processes and Recommendations for Creating mHealth Apps for Low-Income Populations.

JMIR mHealth and uHealth·2017
Same author

Simple risk stratification score for prognosis of syncope.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2016

Related Experiment Video

Updated: Dec 17, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K

Basic principles of risk score formulation in medicine.

Rafael Ronsoni1,2, Bruna Predabon2, Tiago Leiria1

  • 1. Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia, Porto Alegre, RS, Brasil.

Revista Da Associacao Medica Brasileira (1992)
|June 25, 2020
PubMed
Summary

Many medical risk models have methodological flaws, leading to inadequate development and reporting. Improving these methods is crucial for accurate healthcare performance monitoring and clinical validity.

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Related Experiment Videos

Last Updated: Dec 17, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Area of Science:

  • Health Services Research
  • Medical Informatics
  • Biostatistics

Background:

  • Risk models are essential for healthcare performance monitoring.
  • Despite widespread use, existing risk models face methodological challenges.
  • Previous research highlights the importance of robust risk modeling in medicine.

Purpose of the Study:

  • To review and identify methodological problems in the development of medical risk models.
  • To assess the adequacy of reporting and validation processes for risk models.
  • To provide recommendations for improving risk model methodology and reporting.

Main Methods:

  • Systematic review of methodologies employed in medical risk model development.
  • Analysis of common practices in risk factor selection, missing data handling, and sample size determination.
  • Evaluation of the linkage between model development/validation and clinical objectives.

Main Results:

  • Many risk models are developed using ad hoc methods.
  • Key aspects like risk factor selection, missing value imputation, and sample size are often inadequately addressed.
  • Reporting of methodological details is frequently sparse and unclear, impacting model reproducibility and clinical validity.

Conclusions:

  • Significant methodological improvements are needed in the development and reporting of medical risk models.
  • Enhanced transparency and adherence to best practices are essential for ensuring clinical validity.
  • Recommendations are provided to guide future research and improve the reliability of healthcare risk models.